A phase II clinical and pharmacokinetic study of intravenous exatecan mesylate (DX-8951f) in patients with untreated metastatic gastric cancer
Jaffer A. Ajani, Chris Takimoto, Carlos R. Becerra, Alejandro Silva, Luis Baez, Allen Cohn, Pierre Major, Makio Kamida, Kevie Feit, Robert De JagerVolume:
23
Language:
english
Pages:
6
DOI:
10.1007/s10637-005-2907-z
Date:
October, 2005
File:
PDF, 109 KB
english, 2005